二在炎症性疾病中的治疗作用:综合性综述
Jiawen Song1,2, Yushi Liu1,2, Yurou Guo1,2
1State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China.
Inflammopharmacology
|April 3, 2024
概括
来自Stephania tetrandra的Tetrandrine (TET) 通过调节关键信号通路,有效地对抗炎症. 这种天然化合物在不损害免疫功能的情况下为炎症性疾病提供治疗潜力,尽管建议谨慎剂量.
科学领域:
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
- 自然产品 自然产品
背景情况:
- 炎症是一种复杂的病理反应,具有局部和全身的影响.
- 炎症状况可能导致严重的组织损伤和器官功能障碍.
- 传统的中国草药为新型抗炎药物提供了潜在的来源.
研究的目的:
- 审查在炎症条件下二 (TET) 的治疗应用.
- 探索TET在调节炎症通路中的作用机制.
- 评估TET作为治疗各种炎症疾病的潜力.
主要方法:
- 关于四氨酸 (TET) 和其抗炎作用的现有文献的审查.
- 分析TET对关键炎症信号通路的影响,包括NF-κB,MAPK,ERK和STAT3.
- 评估TET在临床前和临床研究中的疗效,用于诸如类风湿性关节炎,肝炎和炎等疾病.
主要成果:
- 二 (TET) 在治疗各种炎症疾病方面表现出显著的疗效.
- TET调节关键的炎症信号通路,逆转病理过程并减少组织损伤.
- 重要的是,TET保留了正常的免疫功能,同时消除了炎症.
结论:
- 二 (TET) 作为治疗炎症疾病的治疗剂显示出相当大的前景.
- 由于TET的半衰期很长,因此需要进一步研究TET的剂量和持续时间.
- 在未来的抗炎药物开发中,TET是有价值的候选药物.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
137
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
137
Therapeutic Index
4.2K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
4.2K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
162
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
162
Centrally Acting Muscle Relaxants: Therapeutic Uses
679
Centrally acting muscle relaxants reduce muscle tone and tension by interfering with the postsynaptic reflexes in the central nervous system.
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
679
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
382
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
382
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
159
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
159


